SVS-1

General Information


DRACP ID  DRACP00391

Peptide Name   SVS-1

Sequence  KVKVKVKVpPTKVKVKVK

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=4.9±0.6µM MTT assay 24h 1
KB Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=6.3±0.7µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=8.1±0.8µM MTT assay 24h 1
MDA-MB-436 Invasive breast carcinoma of no special type Carcinoma IC50=5.6±0.5µM MTT assay 24h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=80.8±12.8µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  p=D-Pro

Chiral  Mix



Physicochemical Information


Formula  C92H173N25O18

Absent amino acids  ACDEFGHILMNQRSWY

Common amino acids  K

Mass  222094

Pl  11.65

Basic residues  8

Acidic residues  0

Hydrophobic residues  7

Net charge  8

Boman Index  -1869

Hydrophobicity  -22.78

Aliphatic Index  112.78

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22413859

Title  Anticancer ?-hairpin peptides: membrane-induced folding triggers activity

Doi 10.1021/ja210569f

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.